Fig. 4From: Chemo-informatics activity prediction, ligand based drug design, Molecular docking and pharmacokinetics studies of some series of 4, 6-diaryl-2-pyrimidinamine derivatives as anti-cancer agentsA: Structure of the lead compound (11) used for the design. B: structure of the template used for the designBack to article page